HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.

Abstract
Previous studies have shown that overexpression of human apolipoprotein C-I (apoC-I) results in moderate hypercholesterolemia and severe hypertriglyceridemia in mice in the presence and absence of apoE. We assessed whether physiological endogenous apoC-I levels are sufficient to modulate plasma lipid levels independently of effects of apoE on lipid metabolism by comparing apolipoprotein E gene-deficient/apolipoprotein C-I gene-deficient (apoe-/-apoc1-/-), apoe-/-apoc1+/-, and apoe-/-apoc1+/+ mice. The presence of the apoC-I gene-dose-dependently increased plasma cholesterol (+45%; P < 0.001) and triglycerides (TGs) (+137%; P < 0.001), both specific for VLDL. Whereas apoC-I did not affect intestinal [3H]TG absorption, it increased the production rate of hepatic VLDL-TG (+35%; P < 0.05) and VLDL-[35S]apoB (+39%; P < 0.01). In addition, apoC-I increased the postprandial TG response to an intragastric olive oil load (+120%; P < 0.05) and decreased the uptake of [3H]TG-derived FFAs from intravenously administered VLDL-like emulsion particles by gonadal and perirenal white adipose tissue (WAT) (-34% and -25%, respectively; P < 0.05). As LPL is the main enzyme involved in the clearance of TG-derived FFAs by WAT, and total postheparin plasma LPL levels were unaffected, these data demonstrate that endogenous apoC-I suffices to attenuate the lipolytic activity of LPL. Thus, we conclude that endogenous plasma apoC-I increases VLDL-total cholesterol and VLDL-TG dose-dependently in apoe-/- mice, resulting from increased VLDL particle production and LPL inhibition.
AuthorsMarit Westerterp, Willeke de Haan, Jimmy F P Berbée, Louis M Havekes, Patrick C N Rensen
JournalJournal of lipid research (J Lipid Res) Vol. 47 Issue 6 Pg. 1203-11 (Jun 2006) ISSN: 0022-2275 [Print] United States
PMID16537968 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein C-I
  • Apolipoproteins C
  • Apolipoproteins E
  • Lipoproteins, VLDL
  • Cholesterol
  • Lipase
  • Lipoprotein Lipase
Topics
  • Animals
  • Apolipoprotein C-I
  • Apolipoproteins C (blood, genetics, physiology)
  • Apolipoproteins E (blood, genetics, physiology)
  • Cholesterol (blood, metabolism)
  • Hyperlipidemias (blood, metabolism)
  • Intestinal Mucosa (metabolism)
  • Lipase (metabolism)
  • Lipoprotein Lipase (analysis, blood, metabolism)
  • Lipoproteins, VLDL (analysis, biosynthesis, blood)
  • Liver (metabolism)
  • Mice
  • Mice, Knockout
  • Postprandial Period

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: